+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Virtual Clinical Trials Market Research Report by Study Design (Expanded Access Trials, Interventional Trials, and Observational Trials), Implication, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5305495
  • Report
  • April 2022
  • Region: Global
  • 181 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • AiCure LLC
  • Covance Inc
  • Everest Global, Inc
  • IQVIA
  • Medable, Inc.
  • Medpace
The Global Virtual Clinical Trials Market size was estimated at USD 2,551.29 million in 2021, USD 3,116.80 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 22.34% to reach USD 8,555.05 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Virtual Clinical Trials to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Study Design, the market was studied across Expanded Access Trials, Interventional Trials, and Observational Trials.
  • Based on Implication, the market was studied across Cardiovascular Disease and Oncology.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Virtual Clinical Trials market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Virtual Clinical Trials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Virtual Clinical Trials Market, including AiCure LLC, Clinical Ink By GI Partners, CliniOps, Inc, Covance Inc, CRF Health By Genstar Capital, ERT, Everest Global, Inc, ICON PLC, IQVIA, LEO Innovation Lab, Medable, Inc., Medidata Solutions, Medpace, Navitas Life Sciences, Inc., Neoteryx, LLC, Oracle Corporation, Parexel International, Pfizer Inc., Science 37, Tenthpin Management Consultants AG, and VirTrial, LLC.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Virtual Clinical Trials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Virtual Clinical Trials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Virtual Clinical Trials Market?
4. What is the competitive strategic window for opportunities in the Global Virtual Clinical Trials Market?
5. What are the technology trends and regulatory frameworks in the Global Virtual Clinical Trials Market?
6. What is the market share of the leading vendors in the Global Virtual Clinical Trials Market?
7. What modes and strategic moves are considered suitable for entering the Global Virtual Clinical Trials Market?
Frequently Asked Questions about the Global Virtual Clinical Trials Market

What is the estimated value of the Global Virtual Clinical Trials Market?

The Global Virtual Clinical Trials Market was estimated to be valued at $2551.3 Million in 2021.

What is the growth rate of the Global Virtual Clinical Trials Market?

The growth rate of the Global Virtual Clinical Trials Market is 22.3%, with an estimated value of $8555.1 Million by 2027.

What is the forecasted size of the Global Virtual Clinical Trials Market?

The Global Virtual Clinical Trials Market is estimated to be worth $8555.1 Million by 2027.

Who are the key companies in the Global Virtual Clinical Trials Market?

Key companies in the Global Virtual Clinical Trials Market include AiCure LLC, Clinical Ink By GI Partners, CliniOps, Inc, Covance Inc, CRF Health By Genstar Capital, ERT, Everest Global, Inc, ICON PLC and LEO Innovation Lab.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AiCure LLC
  • Covance Inc
  • Everest Global, Inc
  • IQVIA
  • Medable, Inc.
  • Medpace

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of telehealth
5.1.1.2. Growing adoption of digitization in healthcare sector globally
5.1.1.3. Proliferation in research and development activities coupled with favorable government support
5.1.2. Restraints
5.1.2.1. Concerns over large data collection, data accuracy and reliability, and technological failure
5.1.3. Opportunities
5.1.3.1. Ongoing technological advancements in healthcare industry
5.1.3.2. Emerging collaborations between biotechnology and clinical research companies
5.1.4. Challenges
5.1.4.1. Cumbersome and difficult process with enrolment and engagement activities
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Virtual Clinical Trials Market, by Study Design
6.1. Introduction
6.2. Expanded Access Trials
6.3. Interventional Trials
6.4. Observational Trials
7. Virtual Clinical Trials Market, by Implication
7.1. Introduction
7.2. Cardiovascular Disease
7.3. Oncology
8. Americas Virtual Clinical Trials Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Virtual Clinical Trials Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Virtual Clinical Trials Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. AiCure LLC
12.2. Clinical Ink By GI Partners
12.3. CliniOps, Inc
12.4. Covance Inc
12.5. CRF Health By Genstar Capital
12.6. ERT
12.7. Everest Global, Inc
12.8. ICON PLC
12.9. IQVIA
12.10. LEO Innovation Lab
12.11. Medable, Inc.
12.12. Medidata Solutions
12.13. Medpace
12.14. Navitas Life Sciences, Inc.
12.15. Neoteryx, LLC
12.16. Oracle Corporation
12.17. Parexel International
12.18. Pfizer Inc.
12.19. Science 37
12.20. Tenthpin Management Consultants AG
12.21. VirTrial, LLC
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: DYNAMICS
FIGURE 2. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2021 VS 2027 (%)
FIGURE 3. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2027
FIGURE 5. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY EXPANDED ACCESS TRIALS, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY EXPANDED ACCESS TRIALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL TRIALS, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL TRIALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL TRIALS, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL TRIALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2021 VS 2027 (%)
FIGURE 12. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2027
FIGURE 14. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 19. ARGENTINA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 20. BRAZIL VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 21. CANADA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 22. MEXICO VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 23. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 24. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 25. AUSTRALIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 26. CHINA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. INDIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. INDONESIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. JAPAN VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. MALAYSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. PHILIPPINES VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. SINGAPORE VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. TAIWAN VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. THAILAND VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. FRANCE VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. GERMANY VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. ITALY VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. NETHERLANDS VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. QATAR VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. RUSSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. SPAIN VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. UNITED ARAB EMIRATES VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. UNITED KINGDOM VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: FPNV POSITIONING MATRIX
FIGURE 49. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 50. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VIRTUAL CLINICAL TRIALS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY EXPANDED ACCESS TRIALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY EXPANDED ACCESS TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY EXPANDED ACCESS TRIALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY EXPANDED ACCESS TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY EXPANDED ACCESS TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL TRIALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL TRIALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL TRIALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL TRIALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 31. ARGENTINA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 32. BRAZIL VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 33. CANADA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 34. MEXICO VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 35. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 36. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 37. AUSTRALIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. CHINA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 39. INDIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 40. INDONESIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. JAPAN VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. MALAYSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 43. PHILIPPINES VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 44. SINGAPORE VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 45. SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. TAIWAN VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. THAILAND VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. FRANCE VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. GERMANY VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. ITALY VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. NETHERLANDS VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. QATAR VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. RUSSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 56. SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. SPAIN VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. UNITED ARAB EMIRATES VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. UNITED KINGDOM VIRTUAL CLINICAL TRIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 60. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: SCORES
TABLE 61. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: BUSINESS STRATEGY
TABLE 62. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: PRODUCT SATISFACTION
TABLE 63. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: RANKING
TABLE 64. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 65. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: MERGER & ACQUISITION
TABLE 66. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 67. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 68. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: INVESTMENT & FUNDING
TABLE 69. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 70. GLOBAL VIRTUAL CLINICAL TRIALS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • AiCure LLC
  • Clinical Ink By GI Partners
  • CliniOps, Inc
  • Covance Inc
  • CRF Health By Genstar Capital
  • ERT
  • Everest Global, Inc
  • ICON PLC
  • IQVIA
  • LEO Innovation Lab
  • Medable, Inc.
  • Medidata Solutions
  • Medpace
  • Navitas Life Sciences, Inc.
  • Neoteryx, LLC
  • Oracle Corporation
  • Parexel International
  • Pfizer Inc.
  • Science 37
  • Tenthpin Management Consultants AG
  • VirTrial, LLC
Note: Product cover images may vary from those shown

Loading
LOADING...